Recalls / Firms / Aurolife Pharma, LLC

Aurolife Pharma, LLC

14 FDA drug recalls on record.

Date	Class	Drug	Status
2023-05-18	Class III	Glycopyrrolate	Terminated
2022-12-16	Class II	Glycopyrrolate	Ongoing
2022-03-17	Class II	Glycopyrrolate	Terminated
2019-08-23	Class II	Allergy Relief (fexofenadine hydrochrloride) tablets, 180 mg, 5-count carton, Good Neighbo	Terminated
2019-08-23	Class II	Allergy Relief (Fexofenadine Hydrochrloride) Tablets USP, 180 mg, packaged in a) 15-count	Terminated
2019-08-23	Class II	Fexofenadine Hydrochloride Tablets USP, 180 mg, packaged in a) 15-count cartons (NDC 62011	Terminated
2019-08-23	Class II	Allergy (Fexofenadine Hydrochloride) Tablets USP, 180 mg, 30-count cartons, DISCOUNT drug	Terminated
2019-08-23	Class II	Allergy (Fexofenadine Hydrochloride) Tablets USP, 180 mg, 30-count bottles, Distributed by	Terminated
2019-08-23	Class II	fexofenadine hydrochloride tablets USP, 180 mg, 150-count bottle, Member's Mark, Distribut	Terminated
2019-08-23	Class II	Fexofenadine HCL Tablets USP, 180 mg, 500's BRITE STOCK; Manufactured for: Aurohealth LLC.	Terminated
2019-08-23	Class II	Fexofenadine Hydrochloride Tablets USP, 180 mg, packaged in a) 30-count carton (NDC 70677-	Terminated
2019-08-23	Class II	Fexofenadine Hydrochrloride Tablets USP, 180 mg, 100-count bottle, Distributed by: Aurohea	Terminated
2019-08-23	Class II	Allergy Relief (Fexofenadine HCl) tablets USP, 180 mg, 15-count cartons, equate, Distribut	Terminated
2019-08-23	Class II	Wal-Fex (Fexofenadine Hydrochloride) Tablets USP, 180 mg, 5-count cartons, Distributed By:	Terminated